Home›Trial›NCT07228559
🔬NCT07228559Phase 1ACTIVE NOT RECRUITING

A Study of Avoralstat In Participants With Diabetic Macular Edema

Study Summary

The goal of this study is to assess the safety and therapeutic potential of a single dose of avoralstat in adult participants with DME.

Conditions
Diabetic Macular Edema (DME)
Interventions / Drugs
avoralstat
View on ClinicalTrials.gov ↗
Sponsor
BCRX
BioCryst Pharmaceuticals
Rare Disease
D36/100
Study Details
Enrollment9 participants
Primary Completion—
Lead SponsorBioCryst Pharmaceuticals
Data Retrieved2026-04-11 04:07:07.352075+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.